Explore
13D/13G Activist Filings
121,560 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Dec 11, 2025 | CAMP | Camp4 Therapeutics Corp | Coastlands Capital LP | 13G/A | 10.0% | 4.9M |
| Dec 11, 2025 | N/A | Top Wealth Group Holding Ltd | Avondale Capital, LLC | 13G | 9.9% | 134K |
| Dec 11, 2025 | NWAX.U | New America Acquisition I Corp. | Washington Muse Investments SPC for and on behalf of Heraclitus SP | 13G | 6.5% | 3.0M |
| Dec 11, 2025 | QNRX | Quoin Pharmaceuticals, Ltd. | Resolute Capital Asset Partners LLC | 13G | 8.5% | 50K |
| Dec 11, 2025 | MGPI | MGP Ingredients, Inc. | Karen Seaberg | 13D/A | 9.7% | 2.1M |
| Dec 11, 2025 | BITI | PROSHARES TRUST | Samuel Patton Black IV | 13G | 7.6% | 438K |
| Dec 11, 2025 | BITI | PROSHARES TRUST | Christopher William Black | 13G | 6.2% | 360K |
| Dec 11, 2025 | PETS | PETMED EXPRESS INC | SilverCape Investments Limited | 13D/A | 12.3% | 2.6M |
| Dec 11, 2025 | STAA | STAAR SURGICAL CO | Yunqi Path Capital Master Fund | 13D/A | 5.1% | 2.5M |
| Dec 11, 2025 | SNWV | SANUWAVE Health, Inc. | MANCHESTER MANAGEMENT CO LLC | 13D/A | 11.1% | 948K |
| Dec 11, 2025 | N/A | Puerto Rico Residents Tax-Free Fund IV, Inc. | Ocean Capital LLC | 13D/A | 6.9% | 636K |
| Dec 11, 2025 | HFRO | HIGHLAND OPPORTUNITIES & INCOME FUND | DONDERO JAMES D | 13D/A | 7.5% | 4.1M |
| Dec 11, 2025 | XCUR | Exicure, Inc. | Sangsangin Investment & Securities Co., Ltd. | 13G/A | 0.0% | 0 |
| Dec 11, 2025 | TRIB | Trinity Biotech plc | MiCo IVD Holdings, LLC | 13D/A | 17.0% | 69.5M |
| Dec 11, 2025 | INDV | INDIVIOR PLC | Two Seas Capital LP | 13D/A | 5.7% | 7.1M |
| Dec 11, 2025 | N/A | Top Wealth Group Holding Ltd | BIGGER CAPITAL FUND L P | 13G | 10.0% | 134K |
| Dec 10, 2025 | HE | HAWAIIAN ELECTRIC INDUSTRIES INC | Arena Holdings Management LLC | 13G | 6.1% | 10.6M |
| Dec 10, 2025 | MNKTQ | Keenova Therapeutics plc | Silver Point Capital, L.P. | 13D/A | 11.9% | 4.7M |
| Dec 10, 2025 | CORZ | Core Scientific, Inc. | Citadel Securities GP LLC | 13G | 5.5% | 17.2M |
| Dec 10, 2025 | PBM | PSYENCE BIOMEDICAL LTD. | KAOS Capital Ltd. | 13D | 16.8% | 314K |
| Dec 10, 2025 | BTTC | Black Titan Corporation | The Sire Group Ltd. | 13G/A | 11.2% | 1.0M |
| Dec 10, 2025 | NWAX.U | New America Acquisition I Corp. | Harraden Circle Investments, LLC | 13G | 6.6% | 2.5M |
| Dec 10, 2025 | SSUP | SUPERIOR INDUSTRIES INTERNATIONAL INC | SUP Parent Holdings, LLC | 13D/A | 0.0% | 0 |
| Dec 10, 2025 | N/A | Liberty Media Corp | John C. Malone | 13D/A | 97.3% | 2.3M |
| Dec 10, 2025 | UWMC | UWM Holdings Corporation | Mat Ishbia | 13D/A | 83.7% | 1.3B |
| Dec 10, 2025 | CFBK | CF BANKSHARES INC. | Castle Creek Capital Partners VII, LP | 13D/A | 6.1% | 388K |
| Dec 10, 2025 | NCPL | Netcapital Inc. | Strategic EP, LLC | 13D/A | 0.0% | 0 |
| Dec 10, 2025 | FULC | FULCRUM THERAPEUTICS, INC. | RA Capital Management, L.P. | 13G/A | 11.2% | 6.1M |
| Dec 10, 2025 | N/A | Artec Global Media, Inc. | Typenex Co-Investment, LLC | 13G/A | 9.9% | 69.9M |
| Dec 10, 2025 | HDSN | HUDSON TECHNOLOGIES INC /NY | Hartree Partners, LP | 13D | 8.7% | 3.8M |
| Dec 10, 2025 | ATXS | Astria Therapeutics, Inc. | Glazer Capital, LLC | 13G | 5.5% | 3.2M |
| Dec 10, 2025 | BLTE | Belite Bio, Inc | Darwin Global Management, Ltd. | 13G | 7.0% | 2.6M |
| Dec 10, 2025 | CMND | Clearmind Medicine Inc. | L.I.A. Pure Capital Ltd. | 13G/A | 10.0% | 6.0M |
| Dec 10, 2025 | CMND | Clearmind Medicine Inc. | Capitalink Ltd. | 13G/A | 10.0% | 6.0M |
| Dec 10, 2025 | PGRE | Paramount Group, Inc. | Saray Value Fund SPC | 13D/A | 5.4% | 12.0M |
| Dec 10, 2025 | NFLT | ETFis Series Trust I | STRATEGIC PLANNING GROUP, LLC | 13G/A | 0.0% | 6K |
| Dec 10, 2025 | ENVB | ENVERIC BIOSCIENCES, INC. | Braeden Lichti | 13G/A | 0.0% | 0 |
| Dec 10, 2025 | ENVB | ENVERIC BIOSCIENCES, INC. | Northstrive Fund II LP | 13G/A | 0.0% | 0 |
| Dec 10, 2025 | MMYT | MakeMyTrip Ltd | GIC Private Ltd | 13G/A | 10.0% | 9.0M |
| Dec 10, 2025 | NCZ | Virtus Convertible & Income Fund II | Advisors Asset Management, Inc. | 13G | 5.3% | 1.0M |
| Dec 10, 2025 | COOT | Australian Oilseeds Holdings Ltd | Arena Investors LP | 13G | 6.3% | 1.8M |
| Dec 10, 2025 | SCIO | FIRST TRUST EXCHANGE-TRADED FUND IV | STRATEGIC PLANNING GROUP, LLC | 13G | 25.3% | 734K |
| Dec 10, 2025 | CXE | MFS HIGH INCOME MUNICIPAL TRUST | Saba Capital Management, L.P. | 13D/A | 5.0% | 1.6M |
| Dec 10, 2025 | N/A | Tiziana Life Sciences Ltd | Chernett Jorey | 13G/A | 5.4% | 6.5M |
| Dec 10, 2025 | AUNA | AUNA S.A. | Fiera Capital (UK) Ltd | 13G | 4.8% | 1.4M |
| Dec 10, 2025 | CCRN | Cross Country Healthcare, Inc. | Magnetar Financial LLC | 13D/A | 5.0% | 1.6M |
| Dec 10, 2025 | CGCT | CARTESIAN GROWTH CORPORATION III | Picton Mahoney Asset Management | 13G | 7.3% | 2.0M |
| Dec 10, 2025 | CGCTU | CARTESIAN GROWTH CORPORATION III | Picton Mahoney Asset Management | 13G/A | 0.0% | 0 |
| Dec 10, 2025 | HSIC | HENRY SCHEIN INC | KKR Hawaii Holdings L.P. | 13D/A | 13.0% | 15.3M |
| Dec 10, 2025 | OVID | Ovid Therapeutics Inc. | Takeda Pharmaceutical Company Limited | 13G/A | 12.3% | 8.8M |